These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Trajectories of body mass index across the lifecourse and associations with post-menopausal breast cancer by estrogen receptor status. Pedersen DC, Aarestrup J, Blond K, Jensen BW, Andersen ZJ, Mellemkjær L, Tjønneland A, Baker JL. Cancer Epidemiol; 2023 Dec; 87():102479. PubMed ID: 37897969 [Abstract] [Full Text] [Related]
4. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Ritte R, Lukanova A, Berrino F, Dossus L, Tjønneland A, Olsen A, Overvad TF, Overvad K, Clavel-Chapelon F, Fournier A, Fagherazzi G, Rohrmann S, Teucher B, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Sieri S, Panico S, Tumino R, Vineis P, Quirós JR, Buckland G, Sánchez MJ, Amiano P, Chirlaque MD, Ardanaz E, Sund M, Lenner P, Bueno-de-Mesquita B, van Gils CH, Peeters PH, Krum-Hansen S, Gram IT, Lund E, Khaw KT, Wareham N, Allen NE, Key TJ, Romieu I, Rinaldi S, Siddiq A, Cox D, Riboli E, Kaaks R. Breast Cancer Res; 2012 May 14; 14(3):R76. PubMed ID: 22583394 [Abstract] [Full Text] [Related]
6. Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: a pooled analysis of 20 prospective cohort studies. van den Brandt PA, Ziegler RG, Wang M, Hou T, Li R, Adami HO, Agnoli C, Bernstein L, Buring JE, Chen Y, Connor AE, Eliassen AH, Genkinger JM, Gierach G, Giles GG, Goodman GG, Håkansson N, Krogh V, Le Marchand L, Lee IM, Liao LM, Martinez ME, Miller AB, Milne RL, Neuhouser ML, Patel AV, Prizment A, Robien K, Rohan TE, Sawada N, Schouten LJ, Sinha R, Stolzenberg-Solomon RZ, Teras LR, Tsugane S, Visvanathan K, Weiderpass E, White KK, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Smith-Warner SA. Eur J Epidemiol; 2021 Jan 14; 36(1):37-55. PubMed ID: 33128203 [Abstract] [Full Text] [Related]
7. Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis. Ma H, Ursin G, Xu X, Lee E, Togawa K, Malone KE, Marchbanks PA, McDonald JA, Simon MS, Folger SG, Lu Y, Sullivan-Halley J, Deapen DM, Press MF, Bernstein L. Breast Cancer Res; 2018 Jan 22; 20(1):5. PubMed ID: 29357906 [Abstract] [Full Text] [Related]
12. Association of breast cancer subtypes and body mass index. Petekkaya I, Sahin U, Gezgen G, Solak M, Yuce D, Dizdar O, Arslan C, Ayyildiz V, Altundag K. Tumori; 2013 Jan 22; 99(2):129-33. PubMed ID: 23748802 [Abstract] [Full Text] [Related]
15. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer. Fagherazzi G, Chabbert-Buffet N, Fabre A, Guillas G, Boutron-Ruault MC, Mesrine S, Clavel-Chapelon F. Int J Obes (Lond); 2012 Mar 22; 36(3):431-9. PubMed ID: 21427693 [Abstract] [Full Text] [Related]